Tech Times of New York
SEE OTHER BRANDS

Hottest science and technology news from New York

Tech Times of New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Times of New York.

Press releases published on June 25, 2025

Hack United Unveils United Hacks V5: A Global Hackathon Equipping Youth Innovation with Essential Soft Skills

Hack United Unveils United Hacks V5: A Global Hackathon Equipping Youth Innovation with Essential Soft Skills

This free three-day event invites students worldwide to build, pitch, and grow, offering $50,000+ in prizes and mentorship from industry professionals. NEW YORK CITY, NY, UNITED STATES, June 25, 2025 /⁨EINPresswire.com⁩/ -- Hack United, a global student- …

2025 NY Digital Awards Announces S 1 Winners: Celebrating Creativity Across Design, Video, Web, and Mobile Excellence

2025 NY Digital Awards Announces S 1 Winners: Celebrating Creativity Across Design, Video, Web, and Mobile Excellence

The 2025 NY Digital Awards has announced its winners from immersive websites and mobile experiences to creative video production and next-generation apps. NEW YORK, NY, UNITED STATES, June 24, 2025 /⁨EINPresswire.com⁩/ -- The 2025 NY Digital Awards has …

New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents

New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents

ALAMEDA, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced the global expansion of its partner program and new Jitterbit University partner curricula. …

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

First Patient Enrolled in Aclarion’s Groundbreaking CLARITY Trial

The first CLARITY patient was enrolled at the Texas Back Institute, a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve …

Santech Holdings Announces Unaudited Financial Results for the First Half of Fiscal Year 2025

Santech Holdings Announces Unaudited Financial Results for the First Half of Fiscal Year 2025

HONG KONG, June 25, 2025 (GLOBE NEWSWIRE) -- Santech Holdings Ltd. (“Santech” or the “Company”) (NASDAQ: STEC) today announced its unaudited financial results for the first half of fiscal year 2025 ended December 31, 2024. Santech is a Cayman Islands …

Agillic approved as ‘SKI’ vendor for the Danish public sector

Agillic approved as ‘SKI’ vendor for the Danish public sector

Press release – Copenhagen, 25 June 2025 – Agillic A/S Agillic has been approved as a SKI vendor under the framework agreement ’02.06 standard software’, allowing organisations across state, regions, and municipalities to include Agillic’s marketing …

Political polarisation is rising globally and posing new challenges for businesses, according to Willis latest report

Political polarisation is rising globally and posing new challenges for businesses, according to Willis latest report

LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Rising political polarisation is associated with increased political violence and unpredictable oscillations in government policies, according to the latest Political Risk Index by Willis (NASDAQ: WTW), a leading …

Haal meer uit de cloud met expertise van AWS en een MSP

Haal meer uit de cloud met expertise van AWS en een MSP

Amsterdam, Nederland, Juni 2025, Sean Tilley, Director of Sales EMEA bij 11:11 Systems, een provider van beheerde infrastructuuroplossingen, gaat dieper in op de basisinformatie van data voor de moderne onderneming en hoe die bedrijven in staat stelt te …

Transformez le cloud en levier de succès en alliant AWS à l’expertise des MSP

Transformez le cloud en levier de succès en alliant AWS à l’expertise des MSP

Paris, France, juin 2025, Sean Tilley, directeur commercial senior chez 11:11 Systems, un MSP reconnu, examine le rôle essentiel des données dans l’entreprise moderne et leur importance pour son fonctionnement. Alors que la complexité et la richesse de l’ …

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)

REYKJAVIK, Iceland and PISCATAWAY, N.J. and LONDON, June 25, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacturing of biosimilar medicines for patients worldwide, Kashiv Biosciences LLC …

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director

Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director Egham, UK – 25 June 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients …

Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy

Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy

Two-part clinical study programme to evaluate change in lean and fat mass in patients receiving two different doses of S-pindolol benzoate whilst 1) receiving the GLP-1 agonist semaglutide; and 2) after cessation of semaglutide treatment Initial proof-of- …

LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations, Houston Helix Park

LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations, Houston Helix Park

LIfT BioSciences Expands U.S. Footprint with New Facility at Portal Innovations, Houston Helix Park London, 25 June 2025– LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech and the global leader in neutrophil immunotherapies, today …

OSE Immunotherapeutics provides an update on ongoing proceedings

OSE Immunotherapeutics provides an update on ongoing proceedings

OSE Immunotherapeutics provides an update on ongoing proceedings Nantes, June 25th, 2025, 8:00 a.m. - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), announces that, following the hearing on June 24th, 2025, regarding the request to retract the …

OSE Immunotherapeutics met à jour l’information sur les procédures en cours

OSE Immunotherapeutics met à jour l’information sur les procédures en cours

OSE Immunotherapeutics met à jour l’information sur les procédures en cours NANTES, France, 25 juin 2025, 8 heures – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) annonce qu’à la suite de l’audience le mardi 24 juin 2025, relative à la demande …

Neues Jitterbit-Partnerprogramm schafft globale Plattform für Unternehmensautomatisierung und KI-Agenten

Neues Jitterbit-Partnerprogramm schafft globale Plattform für Unternehmensautomatisierung und KI-Agenten

FRANKFURT, Deutschland, June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, ein weltweit führender Anbieter für die Beschleunigung von digitalen Transformationsprozessen in Unternehmenssystemen, hat heute die globale Erweiterung seines Partnerprogramms sowie die …

New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents

New Jitterbit Partner Program Enables Global Channel to Deliver Enterprise Automation, AI Agents

FRANKFURT, Germany, June 25, 2025 (GLOBE NEWSWIRE) -- Jitterbit, a global leader in accelerating business transformation for enterprise systems, today announced the global expansion of its partner program and new Jitterbit University partner curricula. …

NextBillion.ai selects TomTom Orbis Maps to deliver enhanced enterprise-grade solutions globally

NextBillion.ai selects TomTom Orbis Maps to deliver enhanced enterprise-grade solutions globally

AMSTERDAM, June 25, 2025 (GLOBE NEWSWIRE) -- TomTom (TOM2), the location technology specialist, and NextBillion.ai, a leading provider of AI-powered mapping solutions for enterprise, today announced an expanded partnership to deliver precise route …

Addex Shareholders Approve All Resolutions at Annual General Meeting

Addex Shareholders Approve All Resolutions at Annual General Meeting

Ad Hoc Announcement Pursuant to Art. 53 LR  Geneva, Switzerland, June 25, 2025 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today …

Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation

Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation

Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation Ongoing phase 2 study evaluating riliprubart for the potential prevention and treatment of active antibody-mediated rejection in kidney …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service